453 related articles for article (PubMed ID: 17419278)
1. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
3. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
[TBL] [Abstract][Full Text] [Related]
4. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
5. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoma: curative resection and adjuvant chemotherapy.
Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
[TBL] [Abstract][Full Text] [Related]
9. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH
Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
13. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative radio-chemotherapy in locally advanced gastric cancer].
Garrido M; Bustos M; Orellana E; Madrid J; Galindo H; Sánchez C; Pimentel F; Guzmán S; Ibáñez L; Butte JM; Alvarez M; Besa P
Rev Med Chil; 2008 Jul; 136(7):844-50. PubMed ID: 18949159
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
[TBL] [Abstract][Full Text] [Related]
18. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
Chang HM; Jung KH; Kim TY; Kim WS; Yang HK; Lee KU; Choe KJ; Heo DS; Bang YJ; Kim NK
Ann Oncol; 2002 Nov; 13(11):1779-85. PubMed ID: 12419751
[TBL] [Abstract][Full Text] [Related]
19. No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Chen S; Chen YB; Zhou ZW; Li W; Sun XW; Xu DZ; Li YF; Guan YX; Feng XY; Zhan YQ
Am J Clin Oncol; 2011 Jun; 34(3):309-13. PubMed ID: 20838324
[TBL] [Abstract][Full Text] [Related]
20. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
Fujii M; Sakabe T; Wakabayashi K; Kochi M; Mochizuki F; Kasakura Y; Yamagata M; Noro M; Osawa T; Iwai S
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
